VRBCF (Virbac) Effect of Exchange Rate Changes: $-3 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRBCF Virbac SA VRBCF
85 GF Score
Price $383.25
GF Value $355.12
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Virbac Effect of Exchange Rate Changes?

Virbac VRBCF 85 Effect of Exchange Rate Changes is $-3 Mil as of Jun. 2026. GuruFocus rates VRBCF with a GF Score™ of 85/100 and a GF Value™ of $355.12 (Fairly Valued). The stock has 2 warning signs investors should review.

Virbac's Effect of Exchange Rate Changes for the six months ended in Jun. 2026 was $3 Mil.

Virbac's Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Jun. 2026 was $-3 Mil.

Virbac Effect of Exchange Rate Changes Historical Data

* Premium members only.

The historical data trend for Virbac's Effect of Exchange Rate Changes can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virbac Effect of Exchange Rate Changes Chart

Virbac Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Effect of Exchange Rate Changes
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.59 -5.10 -5.78 1.02 -17.27

Virbac Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Effect of Exchange Rate Changes Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.97 1.98 -12.47 -5.38 2.81
VRBCF
85GF Score
Virbac SA VRBCF
Effect of Exchange Rate Changes is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Virbac Effect of Exchange Rate Changes Calculation

Effect of Exchange Rate Changes represents the effect of exchange rate changes on cash balances held in foreign currencies.

Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Effect of Exchange Rate Changes of $-3 Mil mean?
Virbac (VRBCF) has a Effect of Exchange Rate Changes of $-3 Mil as of Jun. 2026. Effect of Exchange Rate Changes gives the cumulative effect due to foreign exchange rate fluctuations. View historical data for Virbac.
Is Virbac's Effect of Exchange Rate Changes too high?
Virbac's current Effect of Exchange Rate Changes is $-3 Mil. Overall, Virbac has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Virbac's Effect of Exchange Rate Changes compare to LLY and JNJ?
Virbac's Effect of Exchange Rate Changes of $-3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effect of Exchange Rate Changes for a Drug Manufacturers company?
A good Effect of Exchange Rate Changes depends on the Drug Manufacturers industry context. However, Effect of Exchange Rate Changes should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effect of Exchange Rate Changes mean?
A high Effect of Exchange Rate Changes can signal that a stock is expensive relative to its fundamentals. Effect of Exchange Rate Changes gives the cumulative effect due to foreign exchange rate fluctuations. View historical data for Virbac. Virbac's current Effect of Exchange Rate Changes is $-3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virbac stock overvalued right now?
Based on GuruFocus' analysis, Virbac (VRBCF) is currently considered Fairly Valued. The stock's GF Value™ is $355.12, compared to a current price of $383.25 — trading 7.9% above its estimated fair value. The current Effect of Exchange Rate Changes is $-3 Mil. Virbac's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effect of Exchange Rate Changes calculated?
Effect of Exchange Rate Changes is calculated from a company's financial statements. For Virbac (VRBCF), the current Effect of Exchange Rate Changes is $-3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Virbac (VRBCF) Overvalued in 2026?

Based on GuruFocus' analysis, Virbac stock appears to be overvalued. The current stock price of $383.25 is trading 7.9% above its estimated GF Value™ of $355.12. GuruFocus considers Virbac to be Fairly Valued.

Key valuation signals for VRBCF:

  • Effect of Exchange Rate Changes: $-3 Mil
  • GF Value™: $355.12 vs. price of $383.25 (7.9% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the VRBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Virbac Business Description

Address 13e rue, 1ere avenue 2065, LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
85GF Score

Get the complete analysis for VRBCF

Effect of Exchange Rate Changes is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$383.25
Price
$355.12
GF Value